Partners & Collaborators

Genomic Health actively partners and collaborates with academic and industry organizations to develop new products and distribute its individualized genomic-based clinical laboratory services.

Genomic Health collaborates with leading academic cancer centers and a number of organizations, including:

  • The National Surgical Adjuvant Breast and Bowel Project (NSABP)
  • Northern California Kaiser Permanente
  • Eastern Cooperative Oncology Group (ECOG)
  • Southwest Oncology Group (SWOG)

Collaborations focus on the conduct of extensive clinical research using genomic analyses of tumor tissue to enhance information about individualized prognosis and for use in treatment decision-making. The company sponsors trials with noted clinical collaborators at universities, community hospitals, comprehensive cancer centers and cooperative groups in the United States, Asia and Europe.

Genomic Health also partners with leading companies developing oncology therapeutics to investigate and develop genomic-based testing to predict the likelihood of response to targeted therapeutics in various tumor types. The company focuses on increasing the value proposition of clinical treatment for patients through partnerships with pharmaceutical companies including sanofi-aventis, Bristol-Myers Squibb/ImClone Systems and Pfizer.

Genomic Health maintains a worldwide sales force, including partners who distribute Oncotype DX directly in the following countries and regions:

  • Argentina: GP Pharm
  • Australia: Specialised Therapeutics Pty Ltd (STA) 
  • Bolivia: QUIMFA (La Quimica Farmaceutica S.A.)
  • Bulgaria: iHAS, Ltd.
  • Brazil: Advance Medical
  • Colombia: Amarey Nova Medical S.A.
  • Croatia: Pliva, a member of the TEVA group
  • Czech Republic & Slovakia: Xeneo
  • Greece: GeneKor S.A.
  • Hong Kong: Jacobson Medical Limited
  • Hungary: Med Gen-Sol, Kft.
  • India: Medilinks, Inc.
  • Israel: OncotesTEVA, a member of the TEVA group
  • Japan: SRL, Inc.  
  • Mexico: Fármacos
  • Middle East and North Africa: New Bridge Pharmaceuticals
  • Paraguay: QUIMFA (La Quimica Farmaceutica S.A.)
  • Portugal: Lusopalex
  • Spain: Palex Medical S.A.
  • South Africa, Botswana, Namibia, and Kenya: Teva Pharmaceuticals (Pty) Ltd.
  • South Korea: Bio-Medical Science Co., Ltd.
  • Taiwan: GenDiscovery Biotechnology, Inc.
  • Thailand: BioStem Co., Ltd.
  • Turkey: Genekor Biyoteknoloji Arastirma Ltd
  • Uruguay: Honimell
  • Venezuela: Fundacion BADAN

Finally, Genomic Health has established and will continue to build technology partnerships designed to ensure access to key scientific innovations. Our technology partners include Incyte Corporation and Roche Molecular Systems.

For more information about our partners, please contact Customer Service

Telephone: US 650-556-9300
Outside of the US 001-650-556-9300

For collaboration inquiries, please contact Business Development

For collaboration inquiries,
please contact:
Business Development